Recruiting Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders NCT04079179 Conditions Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +18 more Locations Phoenix Children's Hospital — Phoenix, Arizona, United States Arkansas Children's Hospital — Little Rock, Arkansas, United States Children's Hospital of Orange County — Orange, California, United States UCSF Benioff Children's Hospital — San Francisco, California, United States View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Mirdametinib in Histiocytic Disorders NCT06153173 Conditions Hemic and Lymphatic Diseases, Histiocytic Disorders, Histiocytosis, +13 more Locations Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States View Trial Details
Active, Not Recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) NCT03155620 Conditions Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +99 more Locations Children's Hospital of Alabama — Birmingham, Alabama, United States Providence Alaska Medical Center — Anchorage, Alaska, United States Banner Children's at Desert — Mesa, Arizona, United States Phoenix Childrens Hospital — Phoenix, Arizona, United States View all 172 locations View more locations Show fewer locations Loading locations... View Trial Details
